You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Lung cancer

Necitumumab for untreated advanced or metastatic squamous non-small-cell lung cancer

  • Technology appraisal guidance
  • Reference number: TA411
  • Published:  28 September 2016
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

On this page

  1. Final appraisal determination
  2. Draft guidance
  3. Draft scope documents
  4. Invitation to participate

History

Documents created during the development process.

Final appraisal determination

  • Final appraisal determination

  • Final appraisal determination document (PDF 321 KB)

    Published:
    12 August 2016
  • Committee papers (PDF 286 KB)

    Published:
    12 August 2016
  • Committee papers Slides (PDF 81 KB)

    Published:
    12 August 2016

Draft guidance

  • Appraisal consultation document (PDF 328 KB)

    Published:
    26 May 2016
  • Committee papers (PDF 12.23 MB)

    Published:
    26 May 2016

Draft scope documents

  • Draft scope (pre-referral) (PDF 186 KB)

    Published:
    26 November 2015
  • Provisional matrix (pre-referral) (PDF 177 KB)

    Published:
    26 November 2015

Invitation to participate

  • Final scope (PDF 165 KB)

    Published:
    18 November 2015
  • Final matrix (PDF 175 KB)

    Published:
    18 November 2015
  • Draft scope and provisional matrix comments table (post-referral) (PDF 201 KB)

    Published:
    18 November 2015
  • Equality impact assessment (Scoping) (PDF 64 KB)

    Published:
    18 November 2015
Back to top